Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>In this section: FDA warns of potential lethal outcomes regarding potent drug combination, approved first biosimilar to etanercept for multiple inflammatory diseases, and bans specific chemicals in certain consumer antiseptic wash products.</p>

FDA Actions